MARKER THERAPEUTICS INC's ticker is MRKR and the CUSIP is 57055L107. A total of 49 filers reported holding MARKER THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $152 | -99.9% | 577,537 | -0.3% | 0.00% | – |
Q3 2022 | $213,000 | +11.5% | 579,099 | 0.0% | 0.00% | – |
Q2 2022 | $191,000 | -24.8% | 579,099 | 0.0% | 0.00% | – |
Q1 2022 | $254,000 | -51.9% | 579,099 | +4.2% | 0.00% | – |
Q4 2021 | $528,000 | -43.8% | 555,702 | -0.0% | 0.00% | – |
Q3 2021 | $939,000 | -38.4% | 555,745 | +1.6% | 0.00% | – |
Q2 2021 | $1,525,000 | +40.2% | 546,849 | +12.5% | 0.00% | – |
Q1 2021 | $1,088,000 | +42.8% | 486,026 | -7.6% | 0.00% | – |
Q4 2020 | $762,000 | +0.1% | 525,869 | +3.6% | 0.00% | – |
Q3 2020 | $761,000 | -22.3% | 507,673 | +7.3% | 0.00% | – |
Q2 2020 | $979,000 | +18.8% | 473,344 | +9.0% | 0.00% | – |
Q1 2020 | $824,000 | -67.0% | 434,121 | -49.9% | 0.00% | – |
Q4 2019 | $2,496,000 | +21.0% | 866,750 | +114.6% | 0.00% | – |
Q3 2019 | $2,063,000 | -30.8% | 403,839 | +7.3% | 0.00% | -100.0% |
Q2 2019 | $2,981,000 | +89.6% | 376,461 | +58.0% | 0.00% | – |
Q1 2019 | $1,572,000 | -40.3% | 238,272 | -49.8% | 0.00% | – |
Q4 2018 | $2,634,000 | – | 474,924 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 3,142,857 | $1,163,000 | 0.77% |
NEA Management Company, LLC | 10,714,285 | $3,951,000 | 0.20% |
ACT CAPITAL MANAGEMENT, LLC | 354,400 | $131,000 | 0.18% |
Long Focus Capital Management, LLC | 1,461,000 | $539,000 | 0.05% |
AR ASSET MANAGEMENT INC | 279,000 | $103,000 | 0.03% |
MATRIX ASSET ADVISORS INC/NY | 400,000 | $148,000 | 0.02% |
Mandatum Life Insurance Co Ltd | 99,000 | $37,000 | 0.01% |
WealthTrust Axiom LLC | 22,700 | $8,000 | 0.00% |
Riggs Asset Managment Co. Inc. | 18,500 | $7,000 | 0.00% |
NEVILLE RODIE & SHAW INC | 60,202 | $22,000 | 0.00% |